Ki-Wan Yi

Title: Ki-Wan Yi: Innovator in Glycosylated Proteins

Introduction

Ki-Wan Yi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of glycosylated proteins. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

One of Ki-Wan Yi's latest patents is focused on glycosylated immunoglobulin and immunoadhesin. This invention relates to a glycosylated immunoglobulin or a fragment thereof, which includes an immunoglobulin variant with specific amino acid modifications. The invention also encompasses a glycosylated fusion protein formed by linking a glycosylated immunoglobulin with at least one biologically active protein. Additionally, it includes methods for preparing the glycosylated fusion protein and pharmaceutical compositions containing it. Another notable patent involves thrombopoietin protein variants, which substitute valine for phenylalanine in a binding domain. This invention also includes a DNA encoding the protein variant and methods for its preparation.

Career Highlights

Ki-Wan Yi has worked with notable companies such as Korea Prime Pharm Co., Ltd. and Medexgen Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and protein engineering.

Collaborations

Some of his coworkers include Yong-Hoon Chung and Hoon-Sik Cho. Their collaboration has likely fostered innovation and development in their respective projects.

Conclusion

Ki-Wan Yi is a distinguished inventor whose work in glycosylated proteins holds promise for advancements in medical science. His patents reflect a commitment to innovation and the potential for significant contributions to biotechnology.